← Browse by Condition
Medical Condition
allergic bronchopulmonary aspergillosis
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3
ClinicalMetric tracks all active clinical trials for allergic bronchopulmonary aspergillosis sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 3 1
Top Sponsors
2 trials
1 trial
NCT07362667
Recruiting
A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA
Enrollment
44 pts
Location
China
Sponsor
Qianfoshan Hospital
NCT05444946
Recruiting
Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome
Enrollment
104 pts
Location
India
Sponsor
Post Graduate Institute of Med...
NCT06174922 Phase 3
Recruiting
A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis
Enrollment
300 pts
Location
India
Sponsor
Post Graduate Institute of Med...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology